Creative Financial Designs »

G1 Therapeutics shares owned by Creative Financial Designs

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Creative Financial Designs from 13F filings

Historical chart of Creative Financial Designs investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Creative Financial Designs consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Creative Financial Designs

Quarter filed Position value Share count Share price at filing
2024-03-31 $175k 41k 4.32
2023-12-31 $108k 35k 3.05
2023-09-30 $26k 18k 1.44
2023-06-30 $44k 18k 2.49
2023-03-31 $29k 11k 2.68
2022-12-31 $65k 12k 5.43
2022-09-30 $150k 12k 12.50

More positions owned by Creative Financial Designs

Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Vanguard Russell 1000 Growth Etf Etf (VONG)
Fidelity Total Bond Etf Etf (FBND)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Vanguard Value Etf Etf (VTV)
Vanguard Short Term Corp Bond Fd Etf Etf (VCSH)
Inspire Momentum Etf Etf (GLRY)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)
Vanguard Short-term Treasury Etf Etf (VGSH)
Apple Stock (AAPL)
Ishares 0-5 Year Investment Grade Corporate Bond Etf Etf (SLQD)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Ishares Msci Eafe Growth Etf Etf (EFG)
Amazon Stock (AMZN)
Vanguard Intermediate-term Treasury Etf Etf (VGIT)

View all positions for Creative Financial Designs

Top funds holding G1 Therapeutics

Vanguard Group
Raymond James & Associates
D. E. Shaw & Co
Standard Life Aberdeen
Marshall Wace
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Bank of America Corporation
Jane Street
Connor, Clark & Lunn Investment Management
Level Four Advisory Services
Two Sigma Investments
Man Group
Citadel Advisors
Two Sigma Advisers

View all funds holding G1 Therapeutics